Literature DB >> 8686752

Morphological relationships of von Willebrand factor, type VI collagen, and fibrillin in human vascular subendothelium.

X X Wu1, R E Gordon, R W Glanville, H J Kuo, R R Uson, J H Rand.   

Abstract

von Willebrand factor (vWF) plays an important role in the process of platelet adhesion after endothelial injury by serving as a bridge between constituents of the vascular subendothelium and platelet membrane receptors. We previously presented evidence that type VI collagen microfibrils serve as a binding site for vWF in human vascular subendothelium. However, others have proposed that vWF is not associated with type VI collagen but rather with the thicker elastin-associated microfibrils, which contain several proteins including fibrillin. We therefore investigated the relationships among vWF, type VI collagen, and fibrillin in human vascular subendothelium by immunoelectron microscopy using single- and double-labeling immunogold localization techniques. In addition, we observed the three-dimensional ultrastructure of vWF-microfibril complexes by stereo paired micrographs and stereo viewer. We found that vWF co-localizes only with the type VI collagen microfibrils in subendothelium but not with fibrillin microfibrils or striated collagen. The vWF is present in subendothelium in the form of electron-dense aggregates having diameters varying between 65 and 80 nm that are closely associated with, and enmesh, the type VI collagen microfibrils and have structural similarities to intracellular Weibel-Palade bodies. The occasional co-localization of type VI collagen and fibrillin adjacent to internal elastic lamina was observed. These results are consistent with the hypothesis that type VI collagen, but not fibrillin-containing microfibrils, serves as a physiologically relevant binding site for vWF in the vascular subendothelium, where the type VI collagen-vWF complex may play an important role modulating the hemostatic response to vascular injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8686752      PMCID: PMC1865249     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

1.  Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion.

Authors:  V T Turitto; H J Weiss; T S Zimmerman; I I Sussman
Journal:  Blood       Date:  1985-04       Impact factor: 22.113

2.  Interaction of blood platelets with a microfibrillar extract from adult bovine aorta: requirement for von Willebrand factor.

Authors:  F Fauvel; M E Grant; Y J Legrand; H Souchon; G Tobelem; D S Jackson; J P Caen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

3.  Electron microscopic localization of factor-VIII-related antigen in adult human blood vessels.

Authors:  J H Rand; R E Gordon; I I Sussman; S V Chu; V Solomon
Journal:  Blood       Date:  1982-09       Impact factor: 22.113

4.  Subendothelial deposition of von Willebrand's factor requires the presence of endothelial cells.

Authors:  I I Sussman; J H Rand
Journal:  J Lab Clin Med       Date:  1982-10

5.  Localization of factor-VIII-related antigen in human vascular subendothelium.

Authors:  J H Rand; I I Sussman; R E Gordon; S V Chu; V Solomon
Journal:  Blood       Date:  1980-05       Impact factor: 22.113

6.  Platelet adhesion to collagen and endothelial cell matrix under flow conditions is not dependent on platelet glycoprotein IV.

Authors:  E U Saelman; B Kehrel; K M Hese; P G de Groot; J J Sixma; H K Nieuwenhuis
Journal:  Blood       Date:  1994-06-01       Impact factor: 22.113

7.  Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture.

Authors:  J D Levine; J M Harlan; L A Harker; M L Joseph; R B Counts
Journal:  Blood       Date:  1982-08       Impact factor: 22.113

8.  Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin).

Authors:  E U Saelman; H K Nieuwenhuis; K M Hese; P G de Groot; H F Heijnen; E H Sage; S Williams; L McKeown; H R Gralnick; J J Sixma
Journal:  Blood       Date:  1994-03-01       Impact factor: 22.113

9.  Von Willebrand factor in the vessel wall mediates platelet adherence.

Authors:  H V Stel; K S Sakariassen; P G de Groot; J A van Mourik; J J Sixma
Journal:  Blood       Date:  1985-01       Impact factor: 22.113

10.  Platelet interaction with modified articular cartilage. Its possible relevance to joint repair.

Authors:  D Zucker-Franklin; L Drosenberg
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

View more
  5 in total

1.  Critical von Willebrand factor A1 domain residues influence type VI collagen binding.

Authors:  V H Flood; J C Gill; P A Christopherson; D B Bellissimo; K D Friedman; S L Haberichter; S R Lentz; R R Montgomery
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

2.  The distribution of type VI collagen in the developing tissues of the bovine femoral head.

Authors:  A F Sherwin; D H Carter; C A Poole; J A Hoyland; S Ayad
Journal:  Histochem J       Date:  1999-09

3.  Comparative genomic analysis of innate immunity reveals novel and conserved components in crustacean food crop species.

Authors:  Alvina G Lai; A Aziz Aboobaker
Journal:  BMC Genomics       Date:  2017-05-18       Impact factor: 3.969

4.  Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease.

Authors:  Anthony Fenton; Mark D Jesky; Charles J Ferro; Jacob Sørensen; Morten A Karsdal; Paul Cockwell; Federica Genovese
Journal:  PLoS One       Date:  2017-04-12       Impact factor: 3.240

5.  Novel Immune-Related Gene-Based Signature Characterizing an Inflamed Microenvironment Predicts Prognosis and Radiotherapy Efficacy in Glioblastoma.

Authors:  Hang Ji; Hongtao Zhao; Jiaqi Jin; Zhihui Liu; Xin Gao; Fang Wang; Jiawei Dong; Xiuwei Yan; Jiheng Zhang; Nan Wang; Jianyang Du; Shaoshan Hu
Journal:  Front Genet       Date:  2022-01-17       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.